EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C2H6O3S.C31H33N5O4 |
| Net Charge | 0 |
| Average Mass | 649.770 |
| Monoisotopic Mass | 649.25702 |
| SMILES | CCS(=O)(=O)O.COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1 |
| InChI | InChI=1S/C31H33N5O4.C2H6O3S/c1-34-15-17-36(18-16-34)20-27(37)35(2)24-12-10-23(11-13-24)32-29(21-7-5-4-6-8-21)28-25-14-9-22(31(39)40-3)19-26(25)33-30(28)38;1-2-6(3,4)5/h4-14,19,32H,15-18,20H2,1-3H3,(H,33,38);2H2,1H3,(H,3,4,5)/b29-28-; |
| InChIKey | MMMVNAGRWOJNMW-FJBFXRHMSA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted acid A molecular entity capable of donating a hydron to an acceptor (Brønsted base). |
| Biological Roles: | fibroblast growth factor receptor antagonist An antagonist at the fibroblast growth factor receptor. vascular endothelial growth factor receptor antagonist An antagonist at the vascular endothelial growth factor receptor. tyrosine kinase inhibitor Any protein kinase inhibitor that interferes with the action of tyrosine kinase. |
| Applications: | angiogenesis inhibitor An agent and endogenous substances that antagonize or inhibit the development of new blood vessels. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. antifibrotic agent Any agent which acts to reduce fibrosis. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| nintedanib esylate (CHEBI:85170) has part nintedanib(1+) (CHEBI:85172) |
| nintedanib esylate (CHEBI:85170) has role angiogenesis inhibitor (CHEBI:48422) |
| nintedanib esylate (CHEBI:85170) has role antifibrotic agent (CHEBI:233423) |
| nintedanib esylate (CHEBI:85170) has role antineoplastic agent (CHEBI:35610) |
| nintedanib esylate (CHEBI:85170) has role fibroblast growth factor receptor antagonist (CHEBI:63457) |
| nintedanib esylate (CHEBI:85170) has role tyrosine kinase inhibitor (CHEBI:38637) |
| nintedanib esylate (CHEBI:85170) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207) |
| nintedanib esylate (CHEBI:85170) is a indolyl carboxylic acid (CHEBI:46867) |
| nintedanib esylate (CHEBI:85170) is a organic molecular entity (CHEBI:50860) |
| nintedanib esylate (CHEBI:85170) is a organosulfonate salt (CHEBI:64382) |
| IUPAC Name |
|---|
| methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate ethanesulfonate |
| Synonyms | Source |
|---|---|
| Nintedanib esilate | ChEMBL |
| Nintedanib ethanesulfonate | KEGG DRUG |
| Brand Names | Source |
|---|---|
| Nintedanib accord | ChEMBL |
| Ofev | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| D10396 | KEGG DRUG |
| Registry Numbers | Sources |
|---|---|
| Reaxys:14300928 | Reaxys |
| CAS:656247-18-6 | KEGG DRUG |
| CAS:656247-18-6 | ChemIDplus |
| Citations |
|---|